BOSTON SCIENTIFIC CORP — insider transactions

10 transactions on record · CIK 885725

Aggregates

computed from the filings below
Purchases, 12m
6
count of open-market buys
Sales, 12m
4
count of open-market sales
Buy / sell ratio, 12m
1.50
purchases per sale
Distinct insiders, 12m
7
Bought, 3m
$9.5M
Sold, 3m
$4.7M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$9M
2026-08-03
Director share, 12m
70.0%
of transactions where role is stated
Current run
1 buys
consecutive same-direction transactions
Net 3m flow
$4.8M
purchases minus sales
Total on record
10

Transactions

10 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-262026-08-251Morano Susan EDirectorOpen market purchase2,040$49.22$100.4Kfiling
2026-08-122026-08-111Woodworth EmilySVP, Global Controller and CAOOther2,930$51.19$150Kfiling
2026-08-112026-08-101Monson JonathanEVP and CFOOther9,908$50.46$500Kfiling
2026-08-072026-08-052Habiger David CDirectorOpen market purchase2,100$47.59$99.9Kfiling
2026-08-052026-08-032Mahoney Michael FDirector, Chairman, President & CEOOther22,119$48.43$1.1Mfiling
2026-08-052026-08-032Habiger David CDirectorOpen market purchase1,042$48.07$50.1Kfiling
2026-08-052026-08-032Mahoney Michael FDirector, Chairman, President & CEOOpen market purchase186,240$48.33$9Mfiling
2026-08-052026-08-041Habiger David CDirectorOpen market purchase140$48.59$6.8Kfiling
2026-08-032026-07-313LUDWIG EDWARD JDirectorOpen market purchase5,000$45.48$227.4Kfiling
2026-08-032026-07-313Fitzgerald Joseph MichaelEVP & Group Pres, CardiologyOther64,198$46.73$3Mfiling

Source: U.S. Securities and Exchange Commission, EDGAR